GanedenBC30, a spore-forming probiotic ingredient by Kerry, was approved by Brazilian regulatory agency, ANVISA, for the following health claim: “Bacillus coagulans GBI-30, 6086 can contribute to the health of the gastrointestinal tract.”
GanedenBC30 (Bacillus coagulans GBI-30, 6086), a spore-forming probiotic ingredient by Kerry (Dublin, Ireland), was approved by Brazilian regulatory agency, ANVISA, for the following health claim: “Bacillus coagulans GBI-30, 6086 can contribute to the health of the gastrointestinal tract”, for use in conventional food and beverage categories for children over three years, and adults.
To market or sell finished products with GanedenBC30, they must carry the new claim, register their product separately with ANVISA, and include all required disclaimer statements on packaging.
“Consumers in Brazil are very interested in functional foods and beverages with digestive health benefits, and aware that probiotics can provide them,” said John Quilter, vice president and general manager for GanedenBC30, in a press release. “Our consumer research also shows a high demand for products backed by science, which GanedenBC30 can meet. The volume and quality of evidence supporting its efficacy enabled us to provide the Brazilian authorities with a robust scientific dossier, along with clinical studies.
“As a company committed to research and global growth, we’re delighted that this has resulted in new opportunities for manufacturers,” he continued. “First, brands can offer their consumers a high-quality, science-backed probiotic in an important market. Second, they can leverage the GanedenBC30 brand to differentiate their products and communicate real benefits to consumers.”